These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 34745201)

  • 1. Development and Validation of a Five-RNA-Based Signature and Identification of Candidate Drugs for Neuroblastoma.
    Zhang P; Ma K; Ke X; Liu L; Li Y; Liu Y; Wang Y
    Front Genet; 2021; 12():685646. PubMed ID: 34745201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A signature based on five immune-related genes to predict the survival and immune characteristics of neuroblastoma.
    Ma K; Zhang P; Xia Y; Dong L; Li Y; Liu L; Liu Y; Wang Y
    BMC Med Genomics; 2022 Nov; 15(1):242. PubMed ID: 36419120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma.
    Zhou JG; Liang B; Jin SH; Liao HL; Du GB; Cheng L; Ma H; Gaipl US
    Front Oncol; 2019; 9():1361. PubMed ID: 31867276
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of Stage 4 and Stage 4s Neuroblastoma Identifies Autophagy-Related Gene and LncRNA Signatures Associated With Prognosis.
    Meng X; Li H; Fang E; Feng J; Zhao X
    Front Oncol; 2020; 10():1411. PubMed ID: 32974147
    [No Abstract]   [Full Text] [Related]  

  • 5. Construction and Validation of a 13-Gene Signature for Prognosis Prediction in Medulloblastoma.
    Li C; Zou H; Xiong Z; Xiong Y; Miyagishima DF; Wanggou S; Li X
    Front Genet; 2020; 11():429. PubMed ID: 32508873
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of the molecular characteristics of the tumor-immune interaction and the development of an individualized immune prognostic signature for neuroblastoma.
    Jin W; Zhang Y; Liu Z; Che Z; Gao M; Peng H
    J Cell Physiol; 2021 Jan; 236(1):294-308. PubMed ID: 32510620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel risk signature that combines 10 long noncoding RNAs to predict neuroblastoma prognosis.
    Gao L; Lin P; Chen P; Gao RZ; Yang H; He Y; Chen JB; Luo YG; Xu QQ; Liang SW; Gu JH; Huang ZG; Dang YW; Chen G
    J Cell Physiol; 2020 Apr; 235(4):3823-3834. PubMed ID: 31612488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comprehensive analysis of potential prognostic biomarkers for MYCN-amplified neuroblastoma].
    Fan X; Lu HT; Hou L; Zhang L; Yang BY; Chen WM; Zhang HY; Chen X; Li FJ
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Mar; 22(3):262-268. PubMed ID: 32204764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.
    Hong Y; Lin M; Ou D; Huang Z; Shen P
    BMC Cancer; 2021 Jul; 21(1):831. PubMed ID: 34281531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a Five-Gene Signature Derived From MYCN Amplification and Establishment of a Nomogram for Predicting the Prognosis of Neuroblastoma.
    Xia Y; Li X; Tian X; Zhao Q
    Front Mol Biosci; 2021; 8():769661. PubMed ID: 34950701
    [No Abstract]   [Full Text] [Related]  

  • 13. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
    Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
    BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma.
    Zhao J; Wang L; Wei B
    Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of a novel glycolysis-related gene expression signature for gastrointestinal cancer in the Asian population.
    Xia R; Tang H; Shen J; Xu S; Liang Y; Zhang Y; Gong X; Min Y; Zhang D; Tao C; Wang S; Zhang Y; Yang J; Wang C
    Cancer Cell Int; 2021 Mar; 21(1):154. PubMed ID: 33663535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma.
    Meng X; Fang E; Zhao X; Feng J
    Cancer Med; 2020 Jun; 9(11):3800-3815. PubMed ID: 32216054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
    Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q
    Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Survival-Associated Gene Signature in Lung Cancer Coexisting With COPD.
    Miao TW; Du LY; Xiao W; Mao B; Wang Y; Fu JJ
    Front Oncol; 2021; 11():600243. PubMed ID: 33791201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.